Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Cogito digital therapeutics development platform.
- Who it may be relevant to
- Registry conditions: Substance Use Disorders (SUDs). Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population. And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).
Detailed description
Each participant will be asked to:
* Complete an interactive tutorial describing what Cogito is and how to create a sample guide, sample activities, and a sample survey. * Explore using the various Cogito processes by completing a "functionality scavenger hunt". In this scavenger hunt, participants will be walked through a series of activities to create new guides, activities and surveys. * Complete surveys to provide feedback on participants' experience using Cogito
Interventions
- Other Cogito digital therapeutics development platform
Cogito will provide a turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics for the prevention, treatment and/or management of any disease or disorder. This platform will allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide all the components for building a digital therapeutic for any health condition a
Primary outcome measures
- System Usability Scale [Time frame: To be completed immediately after usability feedback session]
Secondary outcome measures (1)
- Visual Analog Scales [Time frame: To be completed immediately after usability feedback session]
Eligibility criteria
Inclusion criteria
- At least 18 years
- PhD and/or MD-level (or equivalent) scientists at academic institutions or digital health companies at the level of Post-doctoral Fellow or higher.
- Training or trained in substance use disorder (SUDs) research.
- Must state a specific interest in digital therapeutics for SUDs.
Exclusion criteria
- Those who do not meet inclusion criteria.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Other
Study locations
United States · 1 center
- Square 2 Systems — Hanover
Identifiers
NCT: NCT07104396 · 1R43DA060729-01